Vectorite Biomedical Inc. (TPEX:4170)

Vectorite Biomedical Revenue

Vectorite Biomedical had revenue of 27.13M TWD in the half year ending June 30, 2026, with 14.95% growth. This brings the company's revenue in the last twelve months to 54.81M, down -19.28% year-over-year. In the year 2025, Vectorite Biomedical had annual revenue of 61.41M with 6.29% growth. That makes Vectorite Biomedical the 42,640th largest company in the world by revenue and 2,139th in Taiwan.

• Revenue (ttm): 54.81M
• Revenue Growth: -19.28%
• P/S Ratio: 10.02
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 549.33M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	61.41M	3.64M	6.29%
Dec 31, 2024	57.77M	1.92M	3.43%
Dec 31, 2023	55.85M	12.94M	30.15%
Dec 31, 2022	42.91M	14.14M	49.16%
Dec 31, 2021	28.77M	4.23M	17.22%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 6, 2026

Data Sources Report a data error